KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Asset Utilization Ratio (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Asset Utilization Ratio for 14 consecutive years, with 0.5 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 2.52% to 0.5 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.5, a 2.52% increase, with the full-year FY2025 number at 0.51, up 1.89% from a year prior.
  • Asset Utilization Ratio was 0.5 for Q4 2025 at Supernus Pharmaceuticals, up from 0.49 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.5 in Q4 2025 to a low of 0.36 in Q4 2021.
  • A 5-year average of 0.44 and a median of 0.47 in 2024 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: grew 21.75% in 2023, then fell 0.82% in 2025.
  • Supernus Pharmaceuticals' Asset Utilization Ratio stood at 0.36 in 2021, then grew by 9.95% to 0.39 in 2022, then rose by 20.64% to 0.47 in 2023, then increased by 2.99% to 0.49 in 2024, then increased by 2.52% to 0.5 in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Asset Utilization Ratio are 0.5 (Q4 2025), 0.49 (Q3 2025), and 0.49 (Q2 2025).